Form 4: Charles River Laboratories Executive VP William D. Barbo Reports Stock Transaction
SEC Form 4 Filing
Corporate Executive VP & CCO William D. Barbo reported a transaction involving Charles River Laboratories stock on May 29, 2024.
Summary
- On May 29, 2024, William D. Barbo, Corporate Executive VP & CCO of Charles River Laboratories, reported a transaction involving the company's common stock.
- The transaction involved the disposition of 179 shares at a price of $214.51 per share.
- Following the transaction, Barbo directly owns 3,433 shares of common stock and indirectly owns 22,842 shares through a trust.
Sentiment
Score: 5
Explanation: This is a routine filing related to an insider transaction. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information about the transaction.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key executives and their potential impact on the company's stock.
Stakeholder Impact
- The transaction may be of interest to shareholders as it provides insight into the actions of a key executive.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of stock transaction |
| 05/30/2024 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.